Showing results (161-170 of 199) with videos related to
Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
Clinical and Pathological Characteristics of KEAP1- and NFE2L2-Mutated Non-Small Cell Lung Carcinoma (NSCLC)Rieke Frank, Matthias Scheffler, Sabine Merkelbach-Bruse, et al.Lung Cancer (Amsterdam, Netherlands)|April 23, 2022
Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implicationsMatthias Scheffler, Marcel Wiesweg, Sebastian Michels, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 9, 2025
Treatment Sequences in BRAF-V600-Mutated NSCLC: First-Line Targeted Therapy Versus First-Line (Chemo-) ImmunotherapyMarcel Wiesweg, Ali Alaffas, Anna Rasokat, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 10, 2023
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET InhibitionRichard Riedel, Jana Fassunke, Andreas H Scheel, et al.Lung Cancer (Amsterdam, Netherlands)|May 4, 2020
Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutationsMatthias Scheffler, Alessandra Holzem, Anna Kron, et al.Oncotarget|April 15, 2015
ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variabilityMatthias Scheffler, Anne Schultheis, Cristina Teixido, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 5, 2020
Treatment Monitoring of Immunotherapy and Targeted Therapy Using 18F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial ExperiencesNorbert Galldiks, Diana S Y Abdulla, Matthias Scheffler, et al.Advances in Therapy|January 18, 2023
An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion MutationsChristos Chouaid, Lise Bosquet, Nicolas Girard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2025
Molecular and clinical characteristics of patients with non-small cell lung cancer (NSCLC) harboring KRAS G12V mutationsFelix John, Lea Ruge, Malte Verheyen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomographyThomas Zander, Matthias Scheffler, Lucia Nogova, et al.Pageof 20